Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas–Implications for tumor biology and potential clinical utilityMichael C. Frühwald, Christoph Plass, Douglas A. Balster et al.|Oncogene|2001Cited by 93
miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemiaAnn‐Kathrin Eisfeld, Clara D. Bloomfield, Guido Marcucci et al.|Blood|2012Cited by 69